2023
DOI: 10.1242/jcs.261395
|View full text |Cite
|
Sign up to set email alerts
|

30 years of nanobodies – an ongoing success story of small binders in biological research

Desiree I. Frecot,
Theresa Froehlich,
Ulrich Rothbauer

Abstract: A milestone in the field of recombinant binding molecules was achieved 30 years ago with the discovery of single-domain antibodies from which antigen-binding variable domains, better known as nanobodies (Nbs), can be derived. Being only one tenth the size of conventional antibodies, Nbs feature high affinity and specificity, while being highly stable and soluble. In addition, they display accessibility to cryptic sites, low off-target accumulation and deep tissue penetration. Efficient selection methods, such … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 165 publications
0
3
0
Order By: Relevance
“…Tissue clearing was performed as in ( 19 ); samples were immunolabeled with rabbit anti- Collagen IV (ColIV; Abcam ab6586, 1:200) sheep anti-von Willebrand factor (vWf; Genetex GTX74137, 1:100), mouse anti-smooth muscle actin (SMA; Abcam amab7817, 1:200), and rabbit anti-Iba1 (WAKO 019–19,741, 1:200); secondary antibodies (Invitrogen Donkey anti-sheep, anti-rabbit and anti-mouse conjugated with Alexa 488, 555 or 647) or nanobodies ( 20 ) (Synaptic System nanobodies anti-mouse and anti-rabbit conjugated with ATTO Fluor 565 and 647 dyes) were all used at 1:200. Incubations with nanobodies required half the time than with regular antibodies.…”
Section: Methodsmentioning
confidence: 99%
“…Tissue clearing was performed as in ( 19 ); samples were immunolabeled with rabbit anti- Collagen IV (ColIV; Abcam ab6586, 1:200) sheep anti-von Willebrand factor (vWf; Genetex GTX74137, 1:100), mouse anti-smooth muscle actin (SMA; Abcam amab7817, 1:200), and rabbit anti-Iba1 (WAKO 019–19,741, 1:200); secondary antibodies (Invitrogen Donkey anti-sheep, anti-rabbit and anti-mouse conjugated with Alexa 488, 555 or 647) or nanobodies ( 20 ) (Synaptic System nanobodies anti-mouse and anti-rabbit conjugated with ATTO Fluor 565 and 647 dyes) were all used at 1:200. Incubations with nanobodies required half the time than with regular antibodies.…”
Section: Methodsmentioning
confidence: 99%
“…The overexpression of cDNA is widely used to screen gene targets and study functional genomics. In genome-scale genetic screening, people screen gene targets by constructing cDNA libraries, overexpression or introducing foreign genes, and observing phenotypic changes [ 20 , 21 , 22 ]. Since overexpression can significantly increase the expression level of specific genes, it is beneficial to directly observe the corresponding cellular superficial changes after gene expression.…”
Section: Traditional Screening Techniquesmentioning
confidence: 99%
“…In addition to classical human and animal antibodies, significant attention has been given to the development of antiviral nanobodies during the pandemic. This antibody format, composed of VHH domains from camelid heavy-chain-only immunoglobulins, has several important advantages, including high stability, low immunogenicity in humans, ease of constructing oligomers, and the ability to recognize epitopes inaccessible to classical antibodies [ 8 , 9 ]. Given current insights into mechanisms of virus immune evasion [ 10 , 11 ], it is conceivable that at least some of the nanobody epitopes are less prone to mutation escape compared to those of the classical antibodies.…”
Section: Introductionmentioning
confidence: 99%